Our open research trials are crucial in advancing the field of ophthalmology and finding better solutions for our patients. Many patients continue to suffer from dry eyes despite trying many products currently on the market. Our dry-eye research team is here to help connect those patients with cutting-edge treatments that are often the future of dry eye care.

Qualified participants will receive free screenings, evaluations, and treatment options at no cost to them or their insurance. Patients may even receive compensation for their participation. Plus, by participating in these trials, you have the opportunity to help others suffering from these conditions.

Many of our studies also have Spanish translations, enabling native Spanish speakers to participate.

Interested in being a part of advancing eye health? Here are our current open trials:

Neurotrophic Keratitis/Dry Eye/IPL

STATUS

Open, enrolling

PURPOSE

Toyos Clinic is at the forefront of topical treatments for neurotrophic keratitis and dry eye, a disease that can occur with diabetes, herpes infections, or moderate to severe dry eye. Qualified patients may receive compensation, free medical care, and free medications.

Pterygium

STATUS

Open, enrolling

PURPOSE

Sun damage and exposure to the elements can cause a thickening of the conjunctiva or covering of the eye. Generally treated surgically, now there is an opportunity to stop or reverse pterygium development with topical eye drops.

Sjogren’s Dry Eye

STATUS

Open, enrolling

PURPOSE

Sjogren’s is an autoimmune disease associated with difficult-to-treat dry eye disease. This study is for patients with antibody or biopsy-proven Sjogren’s and atypical dry eye to improve their symptoms and find relief.

Autoimmune Dry Eye

STATUS

Open, enrolling

PURPOSE

Autoimmune disorders are known to cause dry eye disease and can be resistant to treatment. We have two studies looking at the effect of certain medications on the signs and symptoms of dry eye, as well as the effect on imaging.